Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Accumulated Expenses (2010 - 2026)

Soligenix's (SNGX) quarterly Accumulated Expenses came in at $43001.0 in Q1 2026, down 98.62% YoY from $3.1 million in Q1 2025, and down 91.19% on a QoQ basis from $488125.0 in Q4 2025.

Soligenix (SNGX) Accumulated Expenses (2010 - 2026) Analysis & Trends

Soligenix (SNGX) has 17 years of Accumulated Expenses data on file, last reported at $43001.0 in Q1 2026.

  • Quarterly Accumulated Expenses fell 98.62% year-over-year to $43001.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43001.0 (down 98.62% YoY) and the FY2025 annual result came in at $488125.0, up 45.08% from the prior year.
  • Accumulated Expenses declined to $43001.0 in Q1 2026, from $488125.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.1 million in Q1 2025 to a low of $43001.0 in Q1 2026.
  • A 5-year average of $1.2 million and a median of $488125.0 in 2025 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2025 — Accumulated Expenses jumped 6110.84% — and 2026, when it plunged 98.62%.
  • Tracing SNGX's Accumulated Expenses over 5 years: stood at $2.3 million in 2022, then slumped by 89.12% to $251115.0 in 2023, then jumped by 33.98% to $336442.0 in 2024, then surged by 45.08% to $488125.0 in 2025, then tumbled by 91.19% to $43001.0 in 2026.
  • The last three Accumulated Expenses figures came in at $43001.0 (Q1 2026), $488125.0 (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Soligenix 6.45 Mn 6.45 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.06 Mn
Mar 31, 2026 43,001.00
Dec 31, 2025 488,125.00
Sep 30, 2025 2.03 Mn
Jun 30, 2025 2.78 Mn
Mar 31, 2025 3.12 Mn
Dec 31, 2024 336,442.00
Sep 30, 2024 1.36 Mn
Jun 30, 2024 80,244.00
Mar 31, 2024 50,216.00
Dec 31, 2023 251,115.00
Sep 30, 2023 55,543.00
Jun 30, 2023 73,861.00
Mar 31, 2023 2.45 Mn
Dec 31, 2022 2.31 Mn
Sep 30, 2022 59,790.00
Jun 30, 2022 2.44 Mn
Mar 31, 2022 2.59 Mn
Dec 31, 2021 2.96 Mn
Sep 30, 2021 58,729.00